The heterogeneic distribution of Helicobacter pylori cag pathogenicity island reflects different pathologies in

Alfizah Hanafiah1, Shaza Azlin Razak1, Hui-Min Neoh2

  • 1Universiti Kebangsaan Malaysia, Faculty of Medicine, Dept. of Medical Microbiology and Immunology, Kuala Lumpur, Malaysia.

Abstract

Insights

The cag-pathogenicity island (cagPAI) in Helicobacter pylori shows variations linked to ethnicity and gastric inflammation. Rearranged cagPAI is associated with higher bacterial density and neutrophil activity, impacting H. pylori pathogenesis.

Area of Science:

  • Microbiology
  • Gastroenterology
  • Genetics

Background:

  • Helicobacter pylori infection is a major cause of gastric inflammation.
  • The cag-pathogenicity island (cagPAI) and its encoded type IV secretion system (T4SS) are key virulence factors.
  • CagA is a significant virulence gene within the cagPAI, contributing to gastric pathology.

Purpose of the Study:

  • To investigate the genetic makeup of the cagPAI in H. pylori isolates from diverse ethnic groups.
  • To determine the association between cagPAI integrity and the histopathological severity of gastric mucosa.

Main Methods:

  • Analysis of all 27 cagPAI genes in 88 H. pylori isolates.
  • Correlation of cagPAI gene presence and intactness with patient ethnicity.
  • Assessment of histopathological scores in gastric biopsies.

Main Results:

  • 96.6% of isolates were cagPAI-positive; only 22.4% had an intact cagPAI, with most being partial/rearranged.
  • Specific cagPAI genes (cag2, cag14, cag4, cag24) showed ethnic associations (Malay, Chinese, Indian).
  • Intactness of the cagPAI region correlated with gastric histopathological scores, with partial cagPAI linked to higher bacterial density and neutrophil activity.

Conclusions:

  • H. pylori cagPAI genotypes and rearrangements are associated with host ethnicity.
  • These variations influence the pathogenesis of H. pylori infection in multi-ethnic populations.
  • Understanding cagPAI diversity is crucial for deciphering H. pylori-associated gastric diseases.

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
921
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
575
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
378
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
801
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
1.5K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
937